勘误：作者对《新型内质网应激诱导剂Sec C通过硫酸化内质网半胱氨酸残基和降解YAP诱导胰腺癌细胞内质网应激从而引发凋亡》[《中国药理学报B》12 (2022) 210 - 227]一文的修正。
Erratum: Author correction to "The novel ER stress inducer Sec C triggers apoptosis by sulfating ER cysteine residues and degrading YAP ER stress in pancreatic cancer cells" [Acta Pharm Sin B 12 (2022) 210-227].
作者信息
Wang Junxia, Chen Minghua, Wang Mengyan, Zhao Wenxia, Zhang Conghui, Liu Xiujun, Cai Meilian, Qiu Yuhan, Zhang Tianshu, Zhou Huimin, Zhao Wuli, Si Shuyi, Shao Rongguang
机构信息
Key Laboratory of Antibiotic Bioengineering, Ministry of Health, Laboratory of Oncology, Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100050, China.
出版信息
Acta Pharm Sin B. 2025 Feb;15(2):1208-1209. doi: 10.1016/j.apsb.2024.10.013. Epub 2024 Oct 30.
Abstract
[This corrects the article DOI: 10.1016/j.apsb.2021.07.004.].
摘要
[本文更正了文章的数字对象标识符：10.1016/j.apsb.2021.07.004。]
相似文献
1
Erratum: Author correction to "The novel ER stress inducer Sec C triggers apoptosis by sulfating ER cysteine residues and degrading YAP ER stress in pancreatic cancer cells" [Acta Pharm Sin B 12 (2022) 210-227].勘误：作者对《新型内质网应激诱导剂Sec C通过硫酸化内质网半胱氨酸残基和降解YAP诱导胰腺癌细胞内质网应激从而引发凋亡》[《中国药理学报B》12 (2022) 210 - 227]一文的修正。
Acta Pharm Sin B. 2025 Feb;15(2):1208-1209. doi: 10.1016/j.apsb.2024.10.013. Epub 2024 Oct 30.
2
The novel ER stress inducer Sec C triggers apoptosis by sulfating ER cysteine residues and degrading YAP ER stress in pancreatic cancer cells.新型内质网应激诱导剂Sec C通过硫酸化内质网半胱氨酸残基并降解胰腺癌细胞中的YAP内质网应激来触发细胞凋亡。
Acta Pharm Sin B. 2022 Jan;12(1):210-227. doi: 10.1016/j.apsb.2021.07.004. Epub 2021 Jul 11.
3
Erratum: Author correction to 'Discovery of the radio-protecting effect of ecliptae herba, its constituents and targeting p53-mediated apoptosis and ' [Acta Pharm Sin B 13 (2023) 1216-1230].勘误：《墨旱莲及其成分的辐射防护作用与靶向p53介导的细胞凋亡》的作者更正 [《中国药理学通报》13 (2023) 1216 - 1230] 。
Acta Pharm Sin B. 2023 Jun;13(6):2815-2816. doi: 10.1016/j.apsb.2023.03.026. Epub 2023 Mar 31.
4
Erratum: Author correction to 'FGF4 protects the liver from immune-mediated injury by activating CaMKK-PINK1 signal pathway to inhibit hepatocellular apoptosis' [Acta Pharm Sin B 14 (2024) 1605-1623].勘误：对“FGF4通过激活CaMKK-PINK1信号通路抑制肝细胞凋亡从而保护肝脏免受免疫介导损伤”一文的作者更正[《药学学报B》14 (2024) 1605-1623]。
Acta Pharm Sin B. 2024 Jun;14(6):2791-2793. doi: 10.1016/j.apsb.2024.04.008. Epub 2024 Apr 9.
5
Erratum: Author correction to 'Pharmacologically targeting molecular motor promotes mitochondrial fission for anti-cancer' [Acta Pharm Sin B 11 (2021) 1853-1866].勘误：“Pharmacologically targeting molecular motor promotes mitochondrial fission for anti-cancer” [《中国药理学报B》11 (2021) 1853-1866]的作者更正。
Acta Pharm Sin B. 2024 May;14(5):2358. doi: 10.1016/j.apsb.2024.02.013. Epub 2024 Feb 21.
6
Erratum: Author correction to "Generation of Gal-enhanced bifunctional tumor vaccine" [Acta Pharm Sin B 12 (2022) 3177-3186].勘误：“Gal增强型双功能肿瘤疫苗的生成”[《中国药理学通报》12 (2022) 3177 - 3186]的作者更正。
Acta Pharm Sin B. 2025 Feb;15(2):1207. doi: 10.1016/j.apsb.2024.11.021. Epub 2024 Nov 29.
7
Erratum: Author correction to "Identification of anthelmintic parbendazole as a therapeutic molecule for HNSCC through connectivity map-based drug repositioning" [Acta Pharm Sin B 12 (2022) 2429-2442].勘误：作者对“通过基于连接图谱的药物重新定位鉴定抗蠕虫药帕苯达唑作为头颈部鳞状细胞癌的治疗分子”[《中国药理学通报》12 (2022) 2429-2442]进行的更正。
Acta Pharm Sin B. 2024 Nov;14(11):5089-5090. doi: 10.1016/j.apsb.2024.09.006. Epub 2024 Sep 10.
8
Erratum: Author correction to "Gas-propelled nanomotors alleviate colitis through the regulation of intestinal immunoenvironment-hematopexis-microbiota circuits" [Acta Pharm Sin B 14 (2024) 2732-2747].勘误：《气体驱动纳米马达通过调节肠道免疫环境-血液结合素-微生物群回路缓解结肠炎》[《药学学报B》14 (2024) 2732-2747]的作者更正。
Acta Pharm Sin B. 2024 Sep;14(9):4193. doi: 10.1016/j.apsb.2024.06.005. Epub 2024 Jun 15.
9
Erratum: Author correction to 'Co-delivery of nigericin and decitabine using hexahistidine-metal nanocarriers for pyroptosis-induced immunotherapeutics' [Acta Pharm Sin B 12 (2022) 4458-4471].勘误：“使用六组氨酸金属纳米载体共递送尼日利亚菌素和地西他滨用于焦亡诱导的免疫治疗”[《中国药理学报B》12 (2022) 4458 - 4471]的作者更正。
Acta Pharm Sin B. 2024 May;14(5):2359-2360. doi: 10.1016/j.apsb.2024.02.021. Epub 2024 Feb 29.
10
Erratum: Author correction to "Tumor-microenvironment activated duplex genome-editing nanoprodrug for sensitized near-infrared titania phototherapy" [Acta Pharm Sin B (2022) 4224-4234].勘误：《肿瘤微环境激活的双链基因组编辑纳米前药用于敏化近红外二氧化钛光疗》[《药学学报B》（2022年）4224 - 4234]的作者更正。
Acta Pharm Sin B. 2024 Feb;14(2):897-899. doi: 10.1016/j.apsb.2023.09.002. Epub 2023 Sep 7.
Zotero 插件